Envoy Medical Current Ratio Growth & History (COCH)
Envoy Medical's current ratio was 0.54 for fiscal 2025.
View full Envoy Medical company overviewEnvoy Medical annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.54 | −0.64 | −53.98% |
| 2024 | 2024-12-31 | 1.18 | 0.16 | +15.31% |
| 2023 | 2023-12-31 | 1.02 | 0.37 | +56.44% |
| 2022 | 2022-12-31 | 0.65 | 0.33 | +102.99% |
| 2021 | 2021-12-31 | 0.32 | — | — |
Envoy Medical quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.73 | 0.80 | +84.72% |
| Q1 2026 | 2026-03-31 | 2.27 | 1.17 | +107.14% |
| Q4 2025 | 2025-12-31 | 0.54 | −0.64 | −53.98% |
| Q3 2025 | 2025-09-30 | 0.64 | −0.15 | −18.55% |
| Q2 2025 | 2025-06-30 | 0.94 | 0.32 | +51.47% |
| Q1 2025 | 2025-03-31 | 1.09 | −0.01 | −0.95% |
| Q4 2024 | 2024-12-31 | 1.18 | 0.16 | +15.31% |
| Q3 2024 | 2024-09-30 | 0.79 | −0.82 | −50.94% |
| Q2 2024 | 2024-06-30 | 0.62 | 0.58 | +1357.26% |
| Q1 2024 | 2024-03-31 | 1.10 | 1.05 | +1930.39% |
| Q4 2023 | 2023-12-31 | 1.02 | 0.37 | +56.44% |
| Q3 2023 | 2023-09-30 | 1.60 | 1.50 | +1530.60% |
| Q2 2023 | 2023-06-30 | 0.04 | −0.14 | −76.23% |
| Q1 2023 | 2023-03-31 | 0.05 | −0.13 | −70.40% |
| Q4 2022 | 2022-12-31 | 0.65 | 0.33 | +102.99% |
| Q3 2022 | 2022-09-30 | 0.10 | −0.59 | −85.82% |
| Q2 2022 | 2022-06-30 | 0.18 | −4.01 | −95.72% |
| Q1 2022 | 2022-03-31 | 0.18 | −34.09 | −99.46% |
| Q4 2021 | 2021-12-31 | 0.32 | 0.06 | +23.37% |
| Q3 2021 | 2021-09-30 | 0.69 | — | — |
| Q2 2021 | 2021-06-30 | 4.18 | — | — |
| Q1 2021 | 2021-03-31 | 34.28 | — | — |
| As of Dec 31, 2020 | 2020-12-31 | 0.26 | — | — |
Envoy Medical current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Envoy Medical's current ratio increased from 0.32 to 0.54, a change of 0.22. The latest reported quarter, Q2 2026, shows 1.73.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Envoy Medical source filings ↗